PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19857560-7	2010	In both cell types, MDZ-stimulated steroidogenesis in dose- and time-dependent manners, and induced the expression of PBR and StAR proteins, but had no effect on P450scc and 3beta-HSD expressions.	Midazolam	20-23	translocator protein	Mus musculus	118-121	
35401924-4	2022	In this study, we evaluated the role of TSPO and its ligands PK11195 and Midazolam in LPS-activated BV-2 microglia cells involving mitophagy process and the nucleotide-binding domain-like receptor protein 3 (NLRP3) inflammasome activation.	Midazolam	73-82	translocator protein	Mus musculus	40-44	
35401924-10	2022	Taken together, TSPO ligands PK11195 and Midazolam showed neuroprotective effects by reducing the inflammatory response of LPS-activated microglia, which may be related to the enhancement of mitophagy and the inhibition of NLRP3 inflammasome.	Midazolam	41-50	translocator protein	Mus musculus	16-20	
33362467-0	2020	TSPO Ligands PK11195 and Midazolam Reduce NLRP3 Inflammasome Activation and Proinflammatory Cytokine Release in BV-2 Cells.	Midazolam	25-34	translocator protein	Mus musculus	0-4	
22014182-10	2012	Pretreatment with the neurosteroid synthesis inhibitors finasteride, a 5alpha-reductase inhibitor, and a functional TSPO antagonist PK 11195, reduced the anticonvulsant action of midazolam.	Midazolam	179-188	translocator protein	Mus musculus	116-120	
22014182-13	2012	CONCLUSION AND IMPLICATIONS: Enhanced endogenous neurosteroid synthesis, possibly mediated by an interaction with TSPO, contributed to the anticonvulsant action of midazolam.	Midazolam	164-173	translocator protein	Mus musculus	114-118	
19857560-10	2010	These results highly indicated that MDZ-induced steroidogenesis in mouse Leydig cells via PKA and PKC pathways, along with the expression of PBR and StAR proteins.	Midazolam	36-39	translocator protein	Mus musculus	141-144